# OnCo record nct07231458 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07231458/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07231458", "NCT07231458" ;
  schema:name "A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies"@en ;
  schema:description "A phase 1 trial of ABX-001 run by Abalos Therapeutics GmbH, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07231458/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07231458> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:drugs <https://onco.cc/drugs/abx-001/> ;
  onco:companies <https://onco.cc/companies/abalos-therapeutics/> .